Steven Gelone
2017
In 2017, Steven Gelone earned a total compensation of $1M as Chief Scientific Officer at Nabriva Therapeutics AG.
Compensation breakdown
| Non-Equity Incentive Plan | $93,766 |
|---|---|
| Option Awards | $535,055 |
| Salary | $370,278 |
| Other | $15,942 |
| Total | $1,015,041 |
Gelone received $535.1K in option awards, accounting for 53% of the total pay in 2017.
Gelone also received $93.8K in non-equity incentive plan, $370.3K in salary and $15.9K in other compensation.
Rankings
In 2017, Steven Gelone's compensation ranked 8,910th out of 14,666 executives tracked by ExecPay. In other words, Gelone earned more than 39.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,910 out of 14,666 | 39th |
Division Manufacturing | 3,401 out of 5,768 | 41st |
Major group Chemicals And Allied Products | 1,157 out of 2,074 | 44th |
Industry group Drugs | 921 out of 1,730 | 47th |
Industry Pharmaceutical Preparations | 723 out of 1,329 | 46th |
Source: SEC filing on June 19, 2018.
Gelone's colleagues
We found three more compensation records of executives who worked with Steven Gelone at Nabriva Therapeutics AG in 2017.